http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01d8c2488cd0f93122b962c3cc516007
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Okuda |
| name | Katsuhiro Okuda |
| given-name | Katsuhiro |
| organization-name | Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Science, Nagoya, Japan Department of Oncology, Immunology and Surgery Nagoya City University Graduate School of Medical Sciences Nagoya Japan Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan Department of Thoracic and Pediatric Surgery Nagoya City University Graduate School of Medical Sciences Nagoya Japan Department of Legal Medicine Asahikawa Medical University Asahikawa Japan Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Science 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. Departments of Oncology, Immunology and Surgery Nagoya City University Graduate School of Medical Sciences Nagoya Japan Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan Department of Oncology, Immunology and Surgery Nagoya City University Graduate School of Medical Sciences Aichi Japan Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya Authors' Affiliations: 1Lowe Center for Thoracic Oncology, Departments of 2Medical Oncology, 3Cancer Biology, and 4Biological Chemistry and Molecular Pharmacology, 5Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 6Pfizer Global Research and Development, Department of Research Pharmacology, La Jolla, California; 7Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts; and Departments of 8Pathology and 9Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Authors' Affiliations: 1Lowe Center for Thoracic Oncology, Departments of 2Medical Oncology, 3Cancer Biology, and 4Biological Chemistry and Molecular Pharmacology, 5Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 6Pfizer Global Research and Development, Department of Research Pharmacology, La Jolla, California; 7Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts; and Departments of 8Pathology and 9Medicine, Brigham and Women's Hospital, Boston, Massachusetts Institute for Materials Chemistry and Engineering, Kyushu University, 6-1 Kasuga-koen, Kasuga, Fukuoka 816-8580, Japan Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan Oncology, Immunology & Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan Graduate School of Biomedical and Health Sciences, Hiroshima University Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya 467‑8601, Japan Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Science, Japan Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan Institute for Materials Chemistry and Engineering Kyushu University Kasugakoen‐6 Kasuga Fukuoka 816‐8580 Japan Faculty of Pharmaceutical Sciences, Hiroshima International University; Graduate School of Biomedical Sciences, Hiroshima University Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan Department of Thoracic and Pediatric Surgery, Nagoya City University Graduate School of Medical Sciences , Nagoya, Japan Authors' Affiliations: Departments of 1Medical Oncology, 2Cancer Biology, 3Biological Chemistry and Molecular Pharmacology, 4Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; Departments of 5Pathology and 6Medicine, Brigham and Women's Hospital, Boston; 7The Broad Institute, Cambridge, Massachusetts; and 8Pfizer Global Research and Development, Department of Research Pharmacology, La Jolla, California; Authors' Affiliations: Departments of 1Medical Oncology, 2Cancer Biology, 3Biological Chemistry and Molecular Pharmacology, 4Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; Departments of 5Pathology and 6Medicine, Brigham and Women's Hospital, Boston; 7The Broad Institute, Cambridge, Massachusetts; and 8Pfizer Global Research and Development, Department of Research Pharmacology, La Jolla, California Institute for Materials Chemistry and Engineering, Kyushu University Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences , Nagoya, Japan Department of Oncology, Immunology and Surgery Nagoya City University Graduate School of Medical Sciences 1 Kawasumi, Mizuho‐cho, Mizuho‐ku 467‐8601 Nagoya Japan Department of Legal Medicine Asahikawa Medical University 2‐1‐1‐1 Midorigaoka‐Higashi Asahikawa 078‐8510 Japan Graduate School of Biomedical and Health Sciences; Hiroshima University; Minami-ku; Japan Department of Oncology, Immunology, and Surgery Nagoya City University Graduate School of Medical Sciences Nagoya Japan Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences Nagoya, Aichi, Japan. |
Incoming Links
Total number of triples: 174.